Concepedia

Publication | Open Access

Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV

DOIFull Paper Access

52

Citations

11

References

2011

Year

Jean‐François Bergmann, Joep de Bruijne, Daphne M. Hotho, Robert J. de Knegt, André Boonstra, Christine J. Weegink, A.A. van Vliet, J. van de Wetering, Simon P. Fletcher, Lisa Bauman,
Alimentary Pharmacology & Therapeutics

Abstract

The ANA773 was generally well tolerated and resulted in a dose-related IFN-dependent response leading to a significant decrease in serum HCV RNA levels in the 2000mg dose group.

References

YearCitations

Page 1